Adam Galan

582 total citations
9 papers, 284 citations indexed

About

Adam Galan is a scholar working on Molecular Biology, Organic Chemistry and Pathology and Forensic Medicine. According to data from OpenAlex, Adam Galan has authored 9 papers receiving a total of 284 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Organic Chemistry and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Adam Galan's work include RNA and protein synthesis mechanisms (2 papers), RNA Research and Splicing (2 papers) and Lung Cancer Treatments and Mutations (1 paper). Adam Galan is often cited by papers focused on RNA and protein synthesis mechanisms (2 papers), RNA Research and Splicing (2 papers) and Lung Cancer Treatments and Mutations (1 paper). Adam Galan collaborates with scholars based in United States, United Kingdom and Netherlands. Adam Galan's co-authors include Houng‐Yau Mei, David P. Mack, D.W. Moreland, Anthony W. Czarnik, Andrea Heldsinger, L Sharmeen, Joseph A. Loo, Kristin A. Sannes‐Lowery, Steven C. Zimmerman and Christopher B. Chapleo and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Pharmacology and Experimental Therapeutics and The Journal of Organic Chemistry.

In The Last Decade

Adam Galan

9 papers receiving 274 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Adam Galan United States	6	239	47	33	28	24	9	284
Ikramul Huq United States	11	341 1.4×	128 2.7×	47 1.4×	18 0.6×	28 1.2×	16	378
Clare Pritchard United Kingdom	7	364 1.5×	118 2.5×	32 1.0×	24 0.9×	20 0.8×	14	410
Cheryl H. Agris United States	8	397 1.7×	34 0.7×	72 2.2×	10 0.4×	36 1.5×	15	475
Koichi Yoshinari Japan	10	370 1.5×	14 0.3×	53 1.6×	12 0.4×	8 0.3×	16	398
Nadia Patino France	12	294 1.2×	42 0.9×	76 2.3×	10 0.4×	24 1.0×	33	361
Horea Porumb France	11	347 1.5×	118 2.5×	40 1.2×	13 0.5×	10 0.4×	22	417
Paul A. Giannaris Canada	9	418 1.7×	14 0.3×	51 1.5×	22 0.8×	3 0.1×	11	441
Victoria Roig France	7	281 1.2×	7 0.1×	35 1.1×	9 0.3×	12 0.5×	13	318
Katrine E. Nielsen Denmark	10	477 2.0×	9 0.2×	59 1.8×	81 2.9×	16 0.7×	14	541
Hirokazu Morisawa Japan	9	289 1.2×	35 0.7×	42 1.3×	15 0.5×	10 0.4×	22	332

Countries citing papers authored by Adam Galan

Since Specialization

Citations

This map shows the geographic impact of Adam Galan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam Galan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam Galan more than expected).

Fields of papers citing papers by Adam Galan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adam Galan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam Galan. The network helps show where Adam Galan may publish in the future.

Co-authorship network of co-authors of Adam Galan

This figure shows the co-authorship network connecting the top 25 collaborators of Adam Galan. A scholar is included among the top collaborators of Adam Galan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adam Galan. Adam Galan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Tulapurkar, Mohan E., Kari Ann Shirey, Wendy Luo, et al.. (2024). First-in-class mitogen-activated protein kinase (MAPK) p38α: MAPK-activated protein kinase 2 dual signal modulator with anti-inflammatory and endothelial-stabilizing properties. Journal of Pharmacology and Experimental Therapeutics. 392(3). 100031–100031. 2 indexed citations

Maestu, I., Cathy A.J. Bosch, V. Giner, et al.. (1999). Carboplatin & gemcitabine in elderly patients with advanced non small cell lung cancer: preliminary results. European Journal of Cancer. 35. S261–S261. 3 indexed citations

Mei, Houng‐Yau, David P. Mack, Adam Galan, et al.. (1997). Discovery of selective, small-molecule inhibitors of RNA complexes—1. The tat protein/TAR RNA complexes required for HIV-1 transcription. Bioorganic & Medicinal Chemistry. 5(6). 1173–1184. 121 indexed citations

Mei, Houng‐Yau, et al.. (1995). Inhibition of an HIV-1 Tat-derived peptide binding to TAR RNA by aminoglycoside antibiotics. Bioorganic & Medicinal Chemistry Letters. 5(22). 2755–2760. 121 indexed citations

Navarro, Guillermo, et al.. (1990). [Intrathecal secretion of antiviral antibodies in multiple sclerosis in patients in Seville].. PubMed. 5(5). 151–4. 1 indexed citations

Galan, Adam, et al.. (1990). Vitamin B12S-promoted model rearrangement of methylmalonate to succinate is not a free radical reaction.. Proceedings of the National Academy of Sciences. 87(8). 3174–3176. 12 indexed citations

Zimmerman, Steven C., et al.. (1989). Synthesis of 2,4(5)-bis(hydroxymethyl)imidazoles and 2,4(5)-bis[(2-hydroxyethoxy)methyl]imidazoles. Precursors of 2,4(5)-connected imidazole crown ethers. The Journal of Organic Chemistry. 54(6). 1256–1264. 13 indexed citations

Lee, Thomas V., Adam Galan, & Christopher B. Chapleo. (1987). The reaction of α-chloro-α-phenylthioketones with phenols: An alternative synthesis of benzofurans. Tetrahedron Letters. 28(20). 2301–2302. 6 indexed citations

Galan, Adam, Thomas V. Lee, & Christopher B. Chapleo. (1986). Novel trichloroacetyl based silylations: simple methods for t-butyldimethylsilylations and for the protection of amino groups.. Tetrahedron Letters. 27(41). 4995–4998. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact